{"favorite_id": 3802, "calc_type": "", "dosing": false, "full_title_en": "Secondary Intracerebral Hemorrhage (sICH) Score", "short_title_en": "sICH Score", "medium_description_en": "Quantifies likelihood of underlying vascular etiology in patients with ICH.", "short_description_en": "Likelihood of vascular cause of ICH.", "before_use": "", "instructions_en": "", "purpose_en": ["Diagnosis", "Prognosis"], "disease_en": ["Stroke/TIA"], "specialty_en": ["Critical Care (Neurologic)", "Emergency Medicine", "Neurology"], "chief_complaint_en": ["AMS", "Headache", "Weakness"], "system_en": ["Neurologic"], "search_abbreviation_en": ["SICH", "vascular etiology", "TIA", "stroke", "cva", "brain", "bleed", "secondary", "ich", "intracranial", "bleed", "angiography", "CTA", "headache"], "slug": "secondary-intracerebral-hemorrhage-sich-score", "seo": {"meta_description_en": "The Secondary Intracerebral Hemorrhage (sICH) Score quantifies likelihood of underlying vascular etiology in patients with ICH.", "keywords_en": "SICH, secondary, ich, intracranial, bleed, angiography, CTA, secondaryICH, sec ICH, intracranial hemorrhage, intracerebral hemorrhage, ICH score, sich score, sich evaluation, sich tool, sich calculator"}, "content": {"how_to_use": {"use_case_en": "<p>Patients with ICH who have had non-contrast CT (NCCT).</p>", "pearls_pitfalls_en": "<ul>\n<li>The Secondary ICH (sICH) Score predicts likelihood that a given ICH is secondary to an underlying vascular abnormality, based on clinical and radiographic characteristics.</li>\n<li>Should not be used for patients with any of the following:\n<ul>\n<li>Subarachnoid hemorrhage in the basal cisterns.</li>\n<li>Clear-cut, pre-established acute ischemic infarct with secondary hemorrhage within the area of infarct.</li>\n<li>Known intracranial vascular abnormality or mass lesion.</li>\n<li>Known probable cerebral amyloid angiopathy per Boston criteria.</li>\n</ul>\n</li>\n<li>Does not predict morbidity or mortality in ICH.</li>\n<li>Difference in discriminatory performance according to imaging interpretations by neurologists vs radiologists has not been determined.</li>\n</ul>", "why_use_en": "<ul> <li>Can help stratify which patients with ICH should undergo CT angiography (CTA) if CTA is not routinely performed for workup of ICH at specific institutions.</li> <li>In select cases, can help determine which patients with ICH should undergo catheter angiogram (the risks of which include, but are not limited to, renal injury, pseudoaneurysm, and arterial dissection) for definitive evaluation for an underlying vascular abnormality.</li> <li>May help with operative planning when emergent neurosurgery for ICH is indicated and either CTA or catheter angiogram cannot be done safely.</li> </ul>"}, "next_steps": {"advice_en": "<ul> <li>Bear in mind that the sICH Score is an adjunct to, and not a substitute for, clinical judgment.</li> <li>In a patient with sICH Score &lt;2 and CTA negative for vascular abnormality, catheter angiogram may present greater procedural risks than benefits from identifying an underlying vascular etiology.</li> <li>In selected patients with sICH Score &gt;2 and CTA negative for vascular abnormality, catheter angiogram may be considered after careful weighing of procedural risks and benefits. Note that CTA is not the gold standard but remains a highly sensitive and specific imaging technique for detecting vascular abnormalities.</li> </ul>", "management_en": "<ul> <li>ICH is a neurological emergency. Immediate neurological and neurosurgical consultation should be obtained on patients with evidence of any ICH on imaging.</li> <li>Hypertensive patients with acute ICH should undergo blood pressure reduction with intravenous agents. The target blood pressure should be discussed with the neurological or neurosurgical consultant.</li> <li>The decision to administer reversal agents (e.g. desmopressin) blood products (e.g. prothrombin factor concentrate, fresh frozen plasma), or anti-epileptic medications should not be made without discussing with the neurological or neurosurgical consultant.</li> <li>Platelet administration is NOT recommended in the setting of antiplatelet-related ICH.</li> </ul>", "critical_actions_en": "<p>It is crucial to identify and reverse anticoagulant-associated ICH&nbsp;(using agents tailored to the underlying anticoagulant).</p>"}, "about": {"formula_en": "<p>Addition of the selected points:</p> <table> <tbody> <tr> <td> <p><strong>Parameter</strong></p> </td> <td> <p><strong>0 points</strong></p> </td> <td> <p><strong>1 point</strong></p> </td> <td> <p><strong>2 points</strong></p> </td> </tr> <tr> <td rowspan=\"2\"> <p><strong>Probability by NCCT Categorization</strong></p> <br><br></td> <td> <p>Low</p> </td> <td> <p>Indeterminate</p> </td> <td> <p>High</p> </td> </tr> <tr> <td> <p>No high-probability criteria present</p> <p>OR</p> <p>Basal ganglia, thalamus, or brainstem location</p> </td> <td> <p>No high or low probability features present</p> </td> <td> <p>Enlarged vessels or calcifications along margins of ICH</p> <p>OR</p> <p>Hyperattenuation within dural venous sinus or cortical vein along the path of drainage of ICH</p> </td> </tr> <tr> <td> <p><strong>Age</strong></p> </td> <td> <p>\u226571 years</p> </td> <td> <p>46-70 years</p> </td> <td> <p>18-45 years</p> </td> </tr> <tr> <td> <p><strong>Sex</strong></p> </td> <td> <p>Male</p> </td> <td> <p>Female</p> </td> <td> <p>--</p> </td> </tr> <tr> <td> <p><strong>Absence of both HTN AND impaired coagulation*</strong></p> </td> <td> <p>No</p> </td> <td> <p>Yes</p> </td> <td> <p>--</p> </td> </tr> </tbody> </table> <p>*Defined as admission INR &gt;3, aPTT &gt;80 seconds, platelet count &lt;50,000, or daily antiplatelet therapy.</p>", "more_info_en": "<p>Interpretation:</p> <table> <tbody> <tr> <td> <p><strong>sICH Score</strong></p> </td> <td> <p><strong>% Positive CTA*</strong></p> </td> </tr> <tr> <td> <p>0</p> </td> <td> <p>0</p> </td> </tr> <tr> <td> <p>1</p> </td> <td> <p>1.5</p> </td> </tr> <tr> <td> <p>2</p> </td> <td> <p>4.4</p> </td> </tr> <tr> <td> <p>3</p> </td> <td> <p>20</p> </td> </tr> <tr> <td> <p>4</p> </td> <td> <p>38.1</p> </td> </tr> <tr> <td> <p>5</p> </td> <td> <p>80</p> </td> </tr> <tr> <td> <p>6</p> </td> <td> <p>100</p> </td> </tr> </tbody> </table> <p>For siCH Score &gt;2, sensitivity: 85.8%, specificity: 72.3%.</p> <p>*CTA showing vascular abnormality, in prospective validation cohort from <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682824/\" target=\"_blank\">Almandoz 2010</a>.</p>", "evidence_based_medicine_en": "<p>The sICH Score was developed by <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682824/\" target=\"_blank\">Almandoz et al in 2010</a> based on retrospective derivation (n = 623) and prospective validation (n = 222) cohorts. In this study, AUCs were not significantly different between derivation and validation cohorts, and the AUC for the combined cohort was 0.87 (95% CI 0.84\u20130.89), with a cut-point of &gt;2 corresponding to 86% sensitivity and 72% specificity (p&lt;0.0001). The study was limited by the use of a retrospective derivation cohort, as well as selection bias from only including patients with ICH that ultimately underwent CTA.</p> <p>Because CTA was originally used to determine presence of vascular abnormality, the sICH was then validated by the <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21808219\" target=\"_blank\">same group in 2012</a> in a retrospective cohort (n = 341) using catheter angiography or intraoperative findings. Again, higher sICH scores were associated with increasing likelihood of harboring an underlying vascular etiology as follows:</p> <ul> <li>sICH 0: 0% positive cases</li> <li>sICH 1: 1.6%</li> <li>sICH 2: 7.8%</li> <li>sICH 3: 18.8%</li> <li>sICH 4: 39.0%</li> <li>sICH 5: 79.2%</li> </ul> <p>AUC in this study was 0.82 with a cut-point of &gt;2 corresponding to sensitivity and specificity of 82% and 66.1%, respectively.</p>", "references_list": {"Original/Primary Reference": [{"href": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682824/", "text": "Almandoz JED, Schaefer PW, Goldstein JN, et al. Practical Scoring System for the Identification of Patients with Intracerebral Hemorrhage at Highest Risk of Harboring an Underlying Vascular Etiology: The Secondary Intracerebral Hemorrhage Score. AJNR American journal of neuroradiology. 2010;31(9):1653-1660. doi:10.3174/ajnr.A2156."}], "Other References": [], "Validation": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/21808219", "text": "Delgado Almandoz JE, Jagadeesan BD, Moran CJ, Cross DT 3rd, Zipfel GJ, Lee JM, Romero JM, Derdeyn CP. Independent validation of the secondary intracerebral hemorrhage score with catheter angiography and findings of emergent hematoma evacuation. Neurosurgery. 2012 Jan;70(1):131-40; discussion 140. doi: 10.1227/NEU.0b013e31822fbf43."}, {"href": "http://stroke.ahajournals.org/content/44/10/2904.long", "text": "van Asch CJ, Velthuis BK, Greving JP, van Laar PJ, Rinkel GJ, Algra A, Klijn CJ. External validation of the secondary intracerebral hemorrhage score in The Netherlands. Stroke. 2013 Oct;44(10):2904-6. doi: 10.1161/STROKEAHA.113.002386. Epub 2013 Aug 6."}], "Clinical Practice Guidelines": [], "Manufacturer Website": [], "Outcomes": []}}, "contributor": {"expert_name": [{"description": "<p>Benjamin Kummer, MD, is currently the inaugural Clinical Informatics fellow at New York Presbyterian Hospital, a joint program with Columbia University\u2019s Department of Biomedical Informatics. A New York City native, Dr. Kummer earned a BA from the University of Pennsylvania before working for several years as a business systems analyst at Capital IQ, a financial technology firm. He received his MD from Drexel University College of Medicine in Philadelphia and completed residency training in neurology at the Neurological Institute of New York at Columbia University Medical Center, followed by a fellowship in stroke neurology at New York-Presbyterian Hospital/Weill-Cornell Medical Center.</p>", "firstName": "Benjamin", "img": "https://cdn-web-img.mdcalc.com/people/bejamin-kummer.jpg", "lastName": "Kummer", "name": "Benjamin Kummer, MD", "target": "benjamin-kummer", "signedCOI": true, "hasDisclosure": [{"org": "Mount Sinai Health System & Icahn School of Medicine at Mt Sinai", "relationship": "Full-time employee (Assistant Professor)"}]}]}, "creator": [{"name": "Dr. Josser Delgado Almandoz", "qa_en": "", "approved": false, "creator_info": {"about_en": "<p>Josser Delgado Almandoz, MD, is a consulting neuroradiologist at Abbott Northwestern Hospital in Minneapolis, MN. He is an active researcher on topics including stroke intervention and other intracranial disease. He was a contributing author to the <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/26892982/\" target=\"_blank\" rel=\"noopener\">Training Guidelines for Endovascular Ischemic Stroke Intervention: An International Multi-Society Consensus Document</a>, a consensus on stroke treatment training of 10 neurological disease societies around the world.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-josser-delgado-almandoz.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Delgado+Almandoz+JE%5Bauth%5D"}}], "reviewer": {"expert_name": []}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [{"id": 215, "order": 0, "society": "EB Medicine", "link": "https://www.ebmedicine.net/topics/stroke/stroke-imaging-modalities-CRAO/calculators", "text": "Calculated Decisions: sICH Score", "description": "Emergency Medicine Practice Extra", "CalculatorId": 3802, "createdAt": "2020-11-24T18:17:05.284Z", "updatedAt": "2020-11-24T18:17:05.284Z"}], "sdm_tool": []}}, "input_schema": [{"type": "radio", "label_en": "Probability of vascular cause on non-contrast computed tomography (NCCT)", "default": 2, "conditionality": "", "show_points": true, "tips_en": "See Evidence > Formula for definitions", "optional": false, "options": [{"label": "High", "value": 2}, {"label": "Indeterminate", "value": 1}, {"label": "Low", "value": 0}], "name": "ncct"}, {"type": "radio", "label_en": "Age", "default": 2, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "18-45 years", "value": 2}, {"label": "46-70 years", "value": 1}, {"label": ">71 years", "value": 0}], "name": "age"}, {"type": "toggle", "label_en": "Sex", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "Male", "value": 0}, {"label": "Female", "value": 1}], "name": "sex"}, {"type": "toggle", "label_en": "Absence of both hypertension AND impaired coagulation", "default": 0, "conditionality": "", "show_points": true, "tips_en": "Impaired coagulation: admission INR >3, aPTT >80 sec, platelet count <50,000, or daily antiplatelet therapy", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "htn"}], "md5": "", "cmeReleaseDate": null, "cmeEndDate": null, "cmeLastReviewed": null, "related_calcs": [{"calcId": 404, "short_title_en": "Hunt & Hess Classification", "slug": "hunt-hess-classification-subarachnoid-hemorrhage"}, {"calcId": 3967, "short_title_en": "ASTRAL Score", "slug": "astral-score-ischemic-stroke"}, {"calcId": 3966, "short_title_en": "mSOAR Score", "slug": "modified-soar-score-stroke"}]}